Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India.

Saved in:
Bibliographic Details
Title: Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India.
Authors: Burza, Sakib1 (AUTHOR) sakibburza@gmail.com, Sinha, Prabhat K.2 (AUTHOR), Mahajan, Raman1 (AUTHOR), Lima, María Angeles3 (AUTHOR), Mitra, Gaurab1 (AUTHOR), Verma, Neena2 (AUTHOR), Balsegaram, Manica4 (AUTHOR), Das, Pradeep2 (AUTHOR)
Source: PLoS Neglected Tropical Diseases. 1/2/2014, Vol. 8 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19352727
DOI:10.1371/journal.pntd.0002536